Daito Pharmaceutical Co's Total Assets for the quarter that ended in Nov. 2025 was 円76,842 Mil.
During the past 12 months, Daito Pharmaceutical Co's average Total Assets Growth Rate was -2.30% per year.
During the past 3 years, the average Total Assets Growth Rate was 7.80% per year.
During the past 5 years, the average Total Assets Growth Rate was 9.00% per year.
During the past 10 years, the average Total Assets Growth Rate was 7.00% per year.
During the past 13 years, Daito Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 12.50%. The lowest was 2.30%. And the median was 7.80%.
Note:
The Net Income data used here is four times the quarterly (Nov. 2025) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Daito Pharmaceutical Co's Asset Turnover for the quarter that ended in Nov. 2025 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Daito Pharmaceutical Co Total Assets Related Terms
Daito Pharmaceutical Co Total Assets Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Daito Pharmaceutical Co's Total Assets for the fiscal year that ended in May. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daito Pharmaceutical Co (TSE:4577) has a Total Assets of 円76,842 Mil as of Nov. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Daito Pharmaceutical Co and its competitors.
Is Daito Pharmaceutical Co's Total Assets too high?
Daito Pharmaceutical Co's current Total Assets is 円76,842 Mil. Overall, Daito Pharmaceutical Co has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Daito Pharmaceutical Co's Total Assets compare to ZTS and UTHR?
Daito Pharmaceutical Co's Total Assets of 円76,842 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Daito Pharmaceutical Co and its competitors. Daito Pharmaceutical Co's current Total Assets is 円76,842 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daito Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Daito Pharmaceutical Co (TSE:4577) is currently considered Fairly Valued. The stock's GF Value™ is 円1,279.92, compared to a current price of 円1,250.00 — trading 2.3% below its estimated fair value. The current Total Assets is 円76,842 Mil. Daito Pharmaceutical Co's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Daito Pharmaceutical Co (TSE:4577), the current Total Assets is 円76,842 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?
Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be undervalued.
The current stock price of 円1,250.00 is trading 2.3% below its estimated GF Value™ of 円1,279.92.
GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.
Key valuation signals for TSE:4577:
Total Assets: 円76,842 Mil
GF Value™: 円1,279.92 vs. price of 円1,250.00 (2.3% below fair value)
No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4577 has been successfully added to your 
